pRetrosuper Myc shRNA Citations (11)
Originally described in: The ubiquitin-specific protease USP28 is required for MYC stability.Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M Nat Cell Biol. 2007 Jul . 9(7):765-74. PubMed Journal
Articles Citing pRetrosuper Myc shRNA
| Articles |
|---|
| Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, Lin LP, Weinstein JN, Ding J. Biochem Pharmacol. 2010 Jul 1;80(1):22-30. doi: 10.1016/j.bcp.2010.02.016. Epub 2010 Mar 3. PubMed |
| Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose. Okuyama H, Endo H, Akashika T, Kato K, Inoue M. Cancer Res. 2010 Dec 15;70(24):10213-23. doi: 10.1158/0008-5472.CAN-10-2720. Epub 2010 Oct 27. PubMed |
| Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Wu I, Shin SC, Cao Y, Bender IK, Jafari N, Feng G, Lin S, Cidlowski JA, Schleimer RP, Lu NZ. Cell Death Dis. 2013 Jan 10;4:e453. doi: 10.1038/cddis.2012.193. PubMed |
| Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells. Sharma BK, Kolhe R, Black SM, Keller JR, Mivechi NF, Satyanarayana A. FASEB J. 2016 Jan;30(1):262-75. doi: 10.1096/fj.15-277749. Epub 2015 Sep 1. PubMed |
| c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL. Lee HY, Cha J, Kim SK, Park JH, Song KH, Kim P, Kim MY. Mol Cancer Res. 2019 Feb;17(2):544-554. doi: 10.1158/1541-7786.MCR-18-0630. Epub 2018 Sep 28. PubMed |
| Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma. Hong J, Maacha S, Belkhiri A. Mol Oncol. 2018 Dec;12(12):2191-2208. doi: 10.1002/1878-0261.12395. Epub 2018 Nov 5. PubMed |
| Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region. Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A. FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec. PubMed |
| The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization. Yan Y, Xu Z, Huang J, Guo G, Gao M, Kim W, Zeng X, Kloeber JA, Zhu Q, Zhao F, Luo K, Lou Z. Nucleic Acids Res. 2020 Dec 16;48(22):12711-12726. doi: 10.1093/nar/gkaa1090. PubMed |
| Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia. Baragano Raneros A, Rodriguez RM, Bernardo Florez A, Palomo P, Colado E, Minguela A, Suarez Alvarez B, Lopez-Larrea C. Oncoimmunology. 2021 Mar 25;10(1):1897294. doi: 10.1080/2162402X.2021.1897294. PubMed |
| Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication. Scarpa M, Kapoor S, Tvedte ES, Doshi KA, Zou YS, Singh P, Lee JK, Chatterjee A, Ali MKM, Bromley RE, Hotopp JCD, Rassool FV, Baer MR. Oncotarget. 2021 Aug 31;12(18):1763-1779. doi: 10.18632/oncotarget.28042. eCollection 2021 Aug 31. PubMed |
| c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity. Serna R, Ramrakhiani A, Hernandez JC, Chen CL, Nakagawa C, Machida T, Ray RB, Zhan X, Tahara SM, Machida K. iScience. 2022 Apr 29;25(6):104325. doi: 10.1016/j.isci.2022.104325. eCollection 2022 Jun 17. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.